Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epide…

この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epide…
この記事を読む
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metast…
この記事を読む
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. Schneider BJ J Clin Oncol. 2020 Mar 1…
この記事を読む
Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer. Haentschel M et al. Lung Cancer. 2020 Mar;14…
この記事を読む
Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with…
この記事を読む
Conservative versus Interventional Treatment for Spontaneous Pneumothorax. Brown SGA et al. N Engl J Med. 2020 Jan 30;38…
この記事を読む
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK Inhib…
この記事を読む
A Novel Algorithm to Differentiate Between Multiple Primary Lung Cancers and Intrapulmonary Metastasis in Multiple Lung …
この記事を読む
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimert…
この記事を読む
Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center r…